drug
GABAPENTIN
Marketedupdated 3mo agoby ACI Healthcare USA Inc
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 8- tagApproval240 co-mentions · 120 sources
- drugGralise127 co-mentions · 127 sources
- drugNeurontin127 co-mentions · 127 sources
- tagSmall Molecule120 co-mentions · 120 sources
- companyActavis Elizabeth LLC18 co-mentions · 18 sources
- companyStrides Pharma Inc13 co-mentions · 13 sources
- tagRecall7 co-mentions · 7 sources
- companySun Pharmaceutical Industries Ltd6 co-mentions · 2 sources
indications
investigational
Epilepsy
all catalysts(59)
approval · 59
Sep 12, 2003
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Apr 6, 2005
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Apr 8, 2005
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Dec 23, 2005
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Dec 5, 2006
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
May 13, 2010
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Feb 11, 2011
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Jun 24, 2011
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Jun 24, 2011
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Aug 30, 2011
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Apr 11, 2012
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Apr 11, 2012
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Aug 28, 2012
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Nov 8, 2014
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Nov 8, 2014
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Mar 16, 2015
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Jan 13, 2016
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Jan 13, 2016
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Mar 24, 2017
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
May 14, 2018
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Oct 16, 2018
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Jul 21, 2020
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Jul 21, 2020
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Sep 16, 2020
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Sep 16, 2020
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Oct 2, 2020
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Oct 2, 2020
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Oct 28, 2020
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Oct 28, 2020
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Oct 28, 2020
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Oct 28, 2020
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Oct 28, 2020
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Apr 26, 2021
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Sep 9, 2021
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Feb 20, 2024
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Jul 16, 2024
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Jul 16, 2024
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Jul 16, 2024
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Jul 16, 2024
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Jul 16, 2024
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Sep 9, 2024
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Oct 3, 2024
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Dec 19, 2024
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Dec 19, 2024
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Dec 19, 2024
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Dec 19, 2024
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Jan 7, 2025
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Jan 7, 2025
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Feb 4, 2025
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Feb 4, 2025
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Jul 21, 2025
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Jul 21, 2025
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Sep 19, 2025
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Nov 24, 2025
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Dec 17, 2025
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Jan 29, 2026
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Jan 29, 2026
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Mar 6, 2026
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Apr 2, 2026
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Trials studying GABAPENTIN
- —Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants
- —A Study Following Women in Menopause Treated With a Non-hormonal Therapy for Hot Flashes and Night Sweats
- phase1A Study on Ketoprofen Lysine Salt (KLS) + Gabapentin (GABA) vs KLS to Investigate Their Pharmacodynamic in Healthy Males
- phase4A Study of Oral Dosing of Gabapentin Enacarbil in Japanese Restless Legs Syndrome Patients
- phase4Post-marketing Study of Gabapentin Enacarbil to Evaluate the Effect in Restless Leg Syndrome (RLS) Patients With Moderate Renal Impairment
- phase2Effect of PP-01 on Cannabis Withdrawal Syndrome
- phase4An Abuse Potential Study of Orally Administered HORIZANT in Healthy, Non-dependent, Recreational Drug Users
- phase4Gabapentin in Phantom and Stump Pain
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 3m ago
Found something off?
comments(0)
5-min edit window · permanent after that